Historically, JPM week has been marked by at least a handful of high-dollar, high-profile acquisition events. This year we ...

Ocugen also reported updated results from a phase 1 trial, which showed that ellipsoid zone (EZ) loss – which results in the ...

What the deals have in common is price reductions for Medicaid, MFN prices for new launches, and discounts for self-paying ...

At the Informa Biotech Showcase during JP Morgan Week in San Francisco, editor-in-chief Jonah Comstock caught up with ...

Taking control of Ocular would also give Sanofi access to its drug delivery platform Elutyx, which could have applications ...

The first data has emerged on the uptake of Novo Nordisk's new oral version of GLP-1 agonist weight-loss therapy Wegovy, with ...

The study analysed more than 3,300 clinical notes produced during regular healthcare visits, from 200 anonymised patients, ...

The era of experimentation is giving way to one of enterprise integration, where scale, safety, and alignment with regulation ...

Top of the list is that AIs must be human-centric by design and align with ethical values. They must be developed using a ...

Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for ...

Novartis has published an open letter to governments around the world, and particularly the EU, Canada, and Japan, urging ...

With attention in biotech focused on the JPM Healthcare conference in the US, the Novo Nordisk Foundation (NNF) has flown the ...